Skip to main content

Articles

Page 1 of 17

  1. Venous thromboembolism (VTE) in pregnancy is a major cause of maternal morbidity and mortality, and the use of preventive low-molecular-weight heparin (LMWH) can be challenging. Clinical guidelines recommend e...

    Authors: Montserrat León‑García, Brittany Humphries, Feng Xie, Derek L. Gravholt, Elizabeth Golembiewski, Mark H. Eckman, Shannon M. Bates, Ian Hargraves, Irene Pelayo, Sandra Redondo López, Juan Antonio Millón Caño, Milagros A. Suito Alcántara, Rohan D’Souza, Nadine Shehata, Susan M. Jack, Gordon Guyatt…
    Citation: Thrombosis Journal 2024 22:81
    Content type: Research Published on:

  2. Coronavirus-19 disease (COVID-19) frequently causes coagulation disturbances. Data remains limited on the effects of microRNAs (miRNAs) on coagulation during COVID-19 infection. We aimed to analyze the compreh...

    Authors: Tuukka A. Helin, Marja Lemponen, Katariina Immonen, Päivi Lakkisto and Lotta Joutsi-Korhonen
    Citation: Thrombosis Journal 2024 22:80
    Content type: Research Published on:

  4. Echinocandins belong to the fourth generation of antifungals, and there are no systematic studies on their risk in coagulation dysfunction; this study will predict the risk of coagulation dysfunction of echino...

    Authors: Qian Cheng, Ye Wu, Zeyu Yao, Mengling Ouyang, Shupeng Zou, Xuan Shi, Yazheng Zhao and Minghui Sun
    Citation: Thrombosis Journal 2024 22:78
    Content type: Research Published on:

  5. Venous thromboembolism (VTE) has a high mortality rate and can be the first manifestation of cancer. We investigated the incidence of cancer after first-ever VTE and the association between VTE and all-cause m...

    Authors: Lovisa Hägg, Felicia Ehrs, Marcus Lind and Magdalena Johansson
    Citation: Thrombosis Journal 2024 22:77
    Content type: Research Published on:

  6. To identify the key risk factors for venous thromboembolism (VTE) in urological inpatients based on the Caprini scale using an interpretable machine learning method.

    Authors: Chao Liu, Wei-Ying Yang, Fengmin Cheng, Ching-Wen Chien, Yen-Ching Chuang and Yanjun Jin
    Citation: Thrombosis Journal 2024 22:76
    Content type: Research Published on:

  7. Atresia of the infrarenal inferior vena cava (IVC) is associated with thrombophilia and antithrombin (AT) deficiency (ATD) due to homozygosity for the so-called Budapest 3 variant, c.391C > T, in the gene, SERPIN...

    Authors: Nina Iversen, Carola Elisabeth Henriksson, Marit Sletten, Marie Skogstad Le, Beate Rikken Lindberg, Rune Andersen and Benedicte Paus
    Citation: Thrombosis Journal 2024 22:75
    Content type: Case Report Published on:

  8. Proper control of the lineage bias of megakaryocytic and erythroid progenitor cells (MEPs) is of significant importance, the disorder of which will lead to abnormalities in the number and function of platelets...

    Authors: Xin Yuan, Pengcong Liu, Lei Xu, Liqing Liang, Qian Dong, Tao Fan, Wen Yue, Mingyi Qu, Xuetao Pei and Xiaoyan Xie
    Citation: Thrombosis Journal 2024 22:74
    Content type: Research Published on:

  9. Exposure to a high-altitude environment is a risk factor for cerebral venous thrombosis (CVT) probably due to hypercoagulability. The study aims to explore the unique characteristics of CVT patients in high-al...

    Authors: Yuhui Sha, Junyi Zhang, Yang Ci, Cidan zhuoga, Yuhua Zhao, Lixin Zhou and Jun Ni
    Citation: Thrombosis Journal 2024 22:73
    Content type: Research Published on:

  10. A recent Phase 2/3 study in Japanese patients showed that caplacizumab was effective in treating immune-mediated thrombotic thrombocytopenic purpura (iTTP), with a low rate of iTTP recurrence. ADAMTS13 activit...

    Authors: Kazunori Imada, Yoshitaka Miyakawa, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Yasuhiro Hashimoto, Masashi Nishimi, Masako Tsukamoto, Sayaka Tahara and Masanori Matsumoto
    Citation: Thrombosis Journal 2024 22:72
    Content type: Research Published on:

  12. Inherited antithrombin, protein C, and protein S deficiency increase the risk of venous thromboembolism. The presence of defects can be identified by clinical laboratory assays. In most Chinese clinical labora...

    Authors: Houmei Feng, Danyu Song, Qiang Xu, Xiaohui Cai, Jianru Liu, Yang Zhang and Zhou Zhou
    Citation: Thrombosis Journal 2024 22:70
    Content type: Research Published on:

  13. Thromboangiitis obliterans (TAO) remains clinical challenging due to its rarity and underwhelming management outcomes. This study aimed to describe a novel TAO rabbit model that demonstrates a closer resemblan...

    Authors: Jia-Long Li, Kristine J. S. Kwan, Xue-Guang Lin, Jie Wang, Bo Chen, Yi-Jie Lu, Bo Wang, Shi-Shuai Xie, Jiong Zhou, Bo Yu, Ying Deng, Shuai Jiang and Jing-Dong Tang
    Citation: Thrombosis Journal 2024 22:69
    Content type: Research Published on:

  14. This study aims to investigate the potential role of Caprini risk assessment model (RAM) in predicting the risk of venous thromboembolism (VTE) in patients undergoing total hip or knee arthroplasty (THA/TKA). ...

    Authors: Zhencan Lin, Hao Sun, Meiyi Chen, Deng Li, Zhiqing Cai, Yimin Wang, Jie Xu and Ruofan Ma
    Citation: Thrombosis Journal 2024 22:68
    Content type: Research Published on:

  15. Thrombocytopenia frequently occurs in patients with sepsis. Disseminated intravascular coagulation (DIC) may be a possible cause of thrombocytopenia owing to its high prevalence and association with poor outco...

    Authors: Kasumi Satoh, Takeshi Wada, Akihito Tampo, Gaku Takahashi, Kota Hoshino, Hironori Matsumoto, Takayuki Taira, Satoshi Kazuma, Takamitsu Masuda, Takashi Tagami and Hiroyasu Ishikura
    Citation: Thrombosis Journal 2024 22:67
    Content type: Review Published on:

  16. This research is one of the pioneering randomized clinical trials (RCTs) aimed at assessing the effectiveness and safety of rivaroxaban in treating left ventricular thrombus (LVT) in patients who have experien...

    Authors: Pejman Mansouri, Zahra Azamian Jazi, Mohammad Hadi Mansouri, Hooman Dehghan, Reihaneh Zavar, Seyedeh Melika Hashemi, Fereshteh Sattar, Masoumeh Sadeghi, Afshin Amirpour and Morteza Abdar
    Citation: Thrombosis Journal 2024 22:66
    Content type: Research Published on:

  17. This study aimed to describe the status of antithrombotic therapy at discharge and prognosis in patients with atrial fibrillation (AF) and chronic coronary syndrome (CCS) who underwent percutaneous coronary in...

    Authors: Yimeng Wang, Yanmin Yang, Lulu Wang, Han Zhang, Jiang-shan Tan and Yuyuan Shu
    Citation: Thrombosis Journal 2024 22:65
    Content type: Research Published on:

  18. The association of low-density lipoprotein cholesterol (LDL-C) and lymphocyte counts with the development of deep vein thrombosis (DVT) has been demonstrated in many fields but remains lacking in open wedge hi...

    Authors: Haichuan Guo, Chengsi Li, Hao Wu, Meixin Ma, Ruoxuan Zhu, Maolin Wang, Bin Yang, Naihao Pan, Yanbin Zhu and Juan Wang
    Citation: Thrombosis Journal 2024 22:64
    Content type: Research Published on:

  19. Deep vein thrombosis (DVT) is common in patients undergoing gynecological surgery. We aimed to investigate the preventive efficacy in DVT of graduated compression stockings (GCS) alone and in combination with ...

    Authors: Limei Lu, Ya Shen and Yuping Pan
    Citation: Thrombosis Journal 2024 22:63
    Content type: Review Published on:

  20. Pulmonary embolism (PE) and deep venous thrombosis (DVT) are the two most important manifestations of venous thromboembolism (VTE). DVT remains a significant condition since associated morbidity is significant...

    Authors: Seble Birhane, Melak Gedamu Beyene, Fishatsion Tadesse and Assefa Mulu Baye
    Citation: Thrombosis Journal 2024 22:62
    Content type: Research Published on:

    The Correction to this article has been published in Thrombosis Journal 2024 22:71

  22. Direct oral anticoagulants are the established drugs for treating pulmonary thromboembolism. The advantage of direct oral anticoagulants over conventional therapy for clot lysis and right ventricular unloading...

    Authors: Hiroya Hayashi, Akihiro Tsuji, Akiyuki Kotoku, Hiroyuki Endo, Naruhiro Nishi, Takatoyo Kiko, Ryotaro Asano, Jin Ueda, Tatsuo Aoki, Tetsuya Fukuda and Takeshi Ogo
    Citation: Thrombosis Journal 2024 22:60
    Content type: Research Published on:

  23. Routine coagulation tests are not widely accepted diagnostic criteria of trauma-induced hypercoagulopathy (TIH) due to insensitivity. Lymphatic vessels drain approximately 10% of the interstitial fluid into th...

    Authors: Yangkang Zheng, Pengyu Wang, Lin Cong, Qi Shi, Yongjian Zhao and YongJun Wang
    Citation: Thrombosis Journal 2024 22:59
    Content type: Research Published on:

  24. Mechanical thrombectomy (MT) has become the mainstay of treatment for acute ischemic stroke (AIS) recently. This case-control study aimed to identify the pivotal role of inflammation in the prognosis of AIS pa...

    Authors: Hong Wang, Xiaobing Tian, Zhangyuan Liao, Xuanye Yue, Libin Sun, Xingrong Li, Ming Zou and Jiayue Ding
    Citation: Thrombosis Journal 2024 22:58
    Content type: Research Published on:

  25. To identify recurrent venous thromboembolism (VTE) after discontinuation of anticoagulation in patients with isolated distal deep vein thrombosis based on its anatomic localization (axial or muscular veins).

    Authors: Wen-Tao Yang, Zhen-Yi Jin, Chun-Min Li, Jia-Hao Wen and Hua-Liang Ren
    Citation: Thrombosis Journal 2024 22:57
    Content type: Review Published on:

  26. Hypercoagulability emerges as a central pathological feature and clinical complication in nephrotic syndrome. Increased platelet activation and aggregability are closely related to hypercoagulability in nephro...

    Authors: Shi-Ping Na, Mei-Liang Ning, Ji-Fang Ma, Shuang Liang, Yan-Li Wang, Man-Shu Sui, Xiao-Fang Guo, Ying Ji, Hui-Yan Lyu, Xue-Ying Yuan and Yu-Shi Bao
    Citation: Thrombosis Journal 2024 22:56
    Content type: Research Published on:

  27. In recent years, extracorporeal membrane oxygenation (ECMO) has been increasingly used in critically ill patients with respiratory or cardiac failure. Heparin is usually used as anticoagulation therapy during ...

    Authors: Danyu Song, Yu Jin, Yang Zhang and Zhou Zhou
    Citation: Thrombosis Journal 2024 22:55
    Content type: Research Published on:

  28. Tuberculosis disease (TB) and tuberculosis infection (TBI) have been associated with increased risk of cardiovascular disease which may be connected to infection-related haemostatic changes. It is unknown if t...

    Authors: Hans Johan Niklas Lorentsson, Christina R. Clausen, Daniel Faurholt-Jepsen, Katrine Bagge Hansen, Sidse Graff Jensen, Rikke Krogh-Madsen, Per G. Hagelqvist, Pär I. Johansson, Tina Vilsbøll, Filip K. Knop and Pernille Ravn
    Citation: Thrombosis Journal 2024 22:54
    Content type: Research Published on:

  29. Platelet is enriched with Circular RNAs (circRNAs), with circFAM13B rank among the 10 most abundant circRNAs in platelets. The aim of the present study was to evaluate the predictive value of platelet-derived ...

    Authors: Yuting Zou, Yuyan Wang, Yanzhu Yao, Yangxun Wu, Chao Lv and Tong Yin
    Citation: Thrombosis Journal 2024 22:53
    Content type: Research Published on:

  30. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a profound global impact, with millions of confirmed cases and deaths worldwide...

    Authors: Kiyohito Hayashi, Daisuke Koyama, Yoichi Hamazaki, Takamichi Kamiyama, Shingo Yamada, Miki Furukawa, Yoshinori Tanino, Yoko Shibata and Takayuki Ikezoe
    Citation: Thrombosis Journal 2024 22:52
    Content type: Research Published on:

  31. The link between venous thromboembolism (VTE) and cancer is well known. VTE could be the initial sign of an occult malignancy. There are more diagnoses of cancer after an unprovoked VTE compared to a provoked ...

    Authors: Maria-Cristina Glodeanu, Victoria Mutruc, Camelia-Maria Apetrei, Manuela Ursaru, Laurentiu Sorodoc and Catalina Lionte
    Citation: Thrombosis Journal 2024 22:51
    Content type: Case Report Published on:

  32. About 13–25% of cerebral venous thrombosis (CVT) cases lack clear etiology, which may be associated with underlying genetic factors. This study aims to investigate genetic factors in CVT patients using whole e...

    Authors: Shaoying Wang, Ming Yao, Xinzhuang Yang, Yicheng Zhu and Bin Peng
    Citation: Thrombosis Journal 2024 22:50
    Content type: Research Published on:

  33. Pulmonary embolism (PE) is a life-threatening thromboembolic disease for which there is limited evidence for effective prevention and treatment. Our goal was to determine whether genetically predicted circulatin...

    Authors: Chen Jiang, Jianing Lin, Bin Xie, Meijuan Peng, Ziyu Dai, Suyin Mai and Qiong Chen
    Citation: Thrombosis Journal 2024 22:49
    Content type: Research Published on:

  34. Risks of recurrence and major bleeding with extended anticoagulation in Asian patients with venous thromboembolism (VTE) are similar to those in non-Asian patients but risks according to baseline risk factor p...

    Authors: Norikazu Yamada, Weiguo Fu, Zhenyu Shi, Ki-Hyuk Park, Hyo-Soo Kim, Xiangchen Dai, Anthonie WA Lensing, Akos F Pap, Tomoko Kohno, Tsubasa Tajima, Tadashi Watakabe and Tomoyuki Mitsumori
    Citation: Thrombosis Journal 2024 22:48
    Content type: Research Published on:

  36. Von Willebrand factor (vWF) plays a crucial role in hemostasis, acting as a key factor for platelet adhesion/aggregation and as a transport protein for coagulation factor VIII. vWF is secreted as a giant multi...

    Authors: Yuki Chiba, Kota Goto, Misako Suzuki, Hisanori Horiuchi and Mineji Hayakawa
    Citation: Thrombosis Journal 2024 22:46
    Content type: Research Published on:

  37. Clinical decision support systems (CDSS) have been utilized as a low-cost intervention to improve healthcare process measures. Thus, we aim to estimate CDSS efficacy to optimize adherence to oral anticoagulant...

    Authors: Ahmed Mazen Amin, Ramy Ghaly, Mohamed T. Abuelazm, Ahmed A. Ibrahim, Mohammad Tanashat, Moumen Arnaout, Obieda Altobaishat, Ahmed Elshahat, Basel Abdelazeem and Sudarshan Balla
    Citation: Thrombosis Journal 2024 22:45
    Content type: Review Published on:

  39. Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently investigating the use of Apixaban in un...

    Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Hadeel Alkofide, Manal A. Aljohani, Hisham A. Badreldin, Mahasen Al Harbi, Ghalia Aquil, Raghad Alhajaji, Rahaf A. Alqahtani, Alaa Babonji, Maha Altuwayr, Asma A. Alshehri, Mashael Alfaifi, Abdullah F. Alharthi, Mohammed Alzahrani, Tareq Al Sulaiman…
    Citation: Thrombosis Journal 2024 22:43
    Content type: Research Published on:

  40. This study aimed to evaluate the association of antiphospholipid antibodies (aPL) and conventional markers of coagulation with ischemic and bleeding risk in patients with atrial fibrillation (AF) undergoing pe...

    Authors: Diona Gjermeni, Viktoria Anfang, Sofia Szabó, Hannah Vetter, Ana C. Venhoff, Stefan Leggewie, David Hesselbarth, Dietmar Trenk, Martin Buechsel, Dirk Westermann and Christoph B. Olivier
    Citation: Thrombosis Journal 2024 22:42
    Content type: Research Published on:

  42. Currently published studies have not observed consistent results on the efficacy and safety of direct oral anticoagulants (DOACs) use in patients with chronic kidney disease (CKD) combined with atrial fibrilla...

    Authors: Yaodi Li, Shuyi Wu, Jintuo Zhou and Jinhua Zhang
    Citation: Thrombosis Journal 2024 22:40
    Content type: Review Published on:

  44. The management of acute pulmonary embolism (PE) has become increasingly complex with the expansion of advanced therapeutic options, resulting in the development and widespread adoption of multidisciplinary Pul...

    Authors: Tiffany A. Gardner, Alexandra Fuher, August Longino, Eric M. Sink, James Jurica, Bryan Park, Jonathan Lindquist, Todd M. Bull and Peter Hountras
    Citation: Thrombosis Journal 2024 22:38
    Content type: Research Published on:

  45. Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused.

    Authors: Mirjana Mitrovic, Nikola Pantic, Zoran Bukumiric, Nikica Sabljic, Marijana Virijevic, Zlatko Pravdic, Mirjana Cvetkovic, Nikola Ilic, Jovan Rajic, Milena Todorovic-Balint, Ana Vidovic, Nada Suvajdzic-Vukovic, Jecko Thachil and Darko Antic
    Citation: Thrombosis Journal 2024 22:37
    Content type: Research Published on:

  46. In this report, we report a case of a middle-aged male, admitted to the ICU with cerebral hemorrhage resulting from a severe high-altitude fall. The patient encountered significant challenges in oxygenation in...

    Authors: Lijie Wang, Chengyong Ma, Luping Wang, Qianrong Ding, Hao Yang, Bo Wang and Qin Wu
    Citation: Thrombosis Journal 2024 22:36
    Content type: Case Report Published on:

  47. Older individuals and, in particular, individuals at risk of recurrent stroke, may be susceptible to thrombosis when participating in exercise, however, this aspect has not been well investigated.

    Authors: L. B. Nørregaard, K. A. Wickham, J. S. Jeppesen, N. Rytter, L. C. Christoffersen, L. Gliemann, M. Lawrence, P. A. Evans, C. Kruuse and Y. Hellsten
    Citation: Thrombosis Journal 2024 22:35
    Content type: Research Published on:

  49. To investigate the genetic underpinnings of the association between type 2 diabetes (T2D), glycemic indicators such as fasting glucose (FG), fasting insulin (FI), and glycated hemoglobin (GH), and venous throm...

    Authors: Mingyi Yang, Xianjie Wan, Yani Su, Ke Xu, Pengfei Wen, Binfei Zhang, Lin Liu, Zhi Yang and Peng Xu
    Citation: Thrombosis Journal 2024 22:33
    Content type: Research Published on:

  50. Antiphospholipid syndrome (APLS) is a systemic immune dysregulation distinguished by repetitive complications and pregnancy loss in the absence of definite etiology. Most research focuses on the laboratory det...

    Authors: Shams ElDoha Galal ElDin Zaiema, Menna Allah Zakaria Mohammad Ali Abou Elwafa, Shaymaa Gamal Arafa Hassan, Radwa Hassan Abou El Fotoh El Adwey, Raghda Mohammed Mostafa Ghorab and Raghda El Sayed Abdel Monem Galal
    Citation: Thrombosis Journal 2024 22:32
    Content type: Research Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.653
    SCImago Journal Rank (SJR): 0.572

    Speed 2023
    Submission to first editorial decision (median days): 11
    Submission to acceptance (median days): 107

    Usage 2023
    Downloads: 708,004
    Altmetric mentions: 943

Thrombosis Journal

ISSN: 1477-9560

Contact us